{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:10Z","timestamp":1792099570775,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["PERIS 2016-2020"],"award-info":[{"award-number":["PERIS 2016-2020"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.chest.2018.11.006","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T05:22:36Z","timestamp":1542864156000},"page":"795-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Effect of Combined \u03b2-Lactam\/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9454-062X","authenticated-orcid":false,"given":"Adrian","family":"Ceccato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-9838","authenticated-orcid":false,"given":"Catia","family":"Cilloniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio T.","family":"Ranzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Gabarrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Niederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9998","key":"10.1016\/j.chest.2018.11.006_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","article-title":"Community-acquired pneumonia","volume":"386","author":"Prina","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.chest.2018.11.006_bib2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1473-3099(15)00151-6","article-title":"Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study","volume":"15","author":"Shindo","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.chest.2018.11.006_bib3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"suppl 6","key":"10.1016\/j.chest.2018.11.006_bib5","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections: full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"14","key":"10.1016\/j.chest.2018.11.006_bib6","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.chest.2018.11.006_bib7","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"\u03b2-Lactam monotherapy vs\u00a0\u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2018.11.006_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","author":"Asadi","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.chest.2018.11.006_bib9","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2014.4304","article-title":"Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia","volume":"311","author":"Mortensen","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","article-title":"Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia","volume":"36","author":"Martin-Loeches","year":"2010","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.chest.2018.11.006_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jama.2016.0115","article-title":"Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chest.2018.11.006_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/thoraxjnl-2012-202296","article-title":"British Thoracic Society. Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia","volume":"68","author":"Rodrigo","year":"2013","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib13","first-page":"342","article-title":"Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: a propensity score analysis","volume":"76","author":"De la Calle","year":"2018","journal-title":"J\u00a0Infect"},{"issue":"6","key":"10.1016\/j.chest.2018.11.006_bib14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jac\/dku033","article-title":"\u03b2-Lactam\/macrolide dual therapy versus \u03b2-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis","volume":"69","author":"Nie","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.chest.2018.11.006_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1183\/09031936.00031007","article-title":"The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis","volume":"30","author":"Paul","year":"2007","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2018.11.006_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.00054108","article-title":"Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia","volume":"33","author":"Restrepo","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2018.11.006_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcrc.2017.08.048","article-title":"Impact of antibiotic therapy in severe community-acquired pneumonia: data from the INFAUCI study","volume":"43","author":"Pereira","year":"2018","journal-title":"J\u00a0Crit Care"},{"issue":"1","key":"10.1016\/j.chest.2018.11.006_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","article-title":"Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators","volume":"31","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.chest.2018.11.006_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkr520","article-title":"Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review","volume":"67","author":"Kovaleva","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.chest.2018.11.006_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","article-title":"Immunomodulatory effects of quinolones","volume":"3","author":"Dalhoff","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.chest.2018.11.006_bib21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1378\/chest.11-1446","article-title":"Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia","volume":"141","author":"Men\u00e9ndez","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a \u03b2-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with\u00a0bacteremic pneumococcal pneumonia","volume":"36","author":"Mart\u00ednez","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.chest.2018.11.006_bib24","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A\u00a0prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2018.11.006_bib26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.chest.2018.11.006_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.chest.2018.11.006_bib28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory\u00a0response: a randomized clinical trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.chest.2018.11.006_bib29","series-title":"Applied Logistic Regression","author":"Hosmer","year":"1989"},{"key":"10.1016\/j.chest.2018.11.006_bib30","series-title":"Statistics: A Tool for Social Research","author":"Healey","year":"2011"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/oxfordjournals.aje.a010011","article-title":"Invited commentary: propensity scores","volume":"150","author":"Joffe","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.chest.2018.11.006_bib32","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.chest.2018.11.006_bib33","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.chest.2018.11.006_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rmed.2018.05.020","article-title":"Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia","volume":"140","author":"Arnold","year":"2018","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2018.11.006_bib35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.chest.2017.01.005","article-title":"Invasive disease vs\u00a0urinary antigen-confirmed pneumococcal community-acquired pneumonia","volume":"151","author":"Ceccato","year":"2017","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cmi.2016.12.002","article-title":"Fluoroquinolones or macrolides in combination with \u03b2-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis","volume":"23","author":"Vardakas","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.chest.2018.11.006_bib37","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ajem.2018.01.079","article-title":"Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: a meta-analysis","volume":"36","author":"Zhang","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.chest.2018.11.006_bib38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/resp.13232","article-title":"Central Japan Lung Study Group. Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: impact of \u03b2-lactam plus macrolide combination therapy","volume":"23","author":"Okumura","year":"2018","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.chest.2018.11.006_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjmed.2007.10.033","article-title":"C-reactive protein is an independent predictor of severity in community-acquired pneumonia","volume":"121","author":"Chalmers","year":"2008","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.chest.2018.11.006_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2007.086785","article-title":"Markers of treatment failure in hospitalised community acquired pneumonia","volume":"63","author":"Men\u00e9ndez","year":"2008","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib41","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc10313","article-title":"Portuguese Community-Acquired Sepsis Study Group (SACiUCI). C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study","volume":"15","author":"P\u00f3voa","year":"2011","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.chest.2018.11.006_bib42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","article-title":"Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)","volume":"44","author":"Welte","year":"2018","journal-title":"Intensive Care Med"},{"issue":"198","key":"10.1016\/j.chest.2018.11.006_bib43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/rccm.201801-0139WS","article-title":"Future research directions in pneumonia: NHLBI Working Group Report","volume":"15","author":"Dela Cruz","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 2","key":"10.1016\/j.chest.2018.11.006_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s15010-005-8209-8","article-title":"Immunomodulatory activities of fluoroquinolones","volume":"33","author":"Dalhoff","year":"2005","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.chest.2018.11.006_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13054-016-1442-y","article-title":"New aspects in the management of pneumonia","volume":"20","author":"Prina","year":"2016","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.chest.2018.11.006_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/426545","article-title":"Nonantimicrobial effects of antibacterial agents","volume":"40","author":"Pasquale","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.chest.2018.11.006_bib47","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jac\/46.5.717","article-title":"Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in\u00a0vitro","volume":"46","author":"Lagrou","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.chest.2018.11.006_bib48","first-page":"527","article-title":"Pneumolysin as a potential therapeutic target in severe pneumococcal disease","volume":"74","author":"Anderson","year":"2017","journal-title":"J\u00a0Infect"},{"issue":"2","key":"10.1016\/j.chest.2018.11.006_bib49","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jac\/dkl479","article-title":"Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae","volume":"59","author":"Anderson","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.chest.2018.11.006_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N\u00a0Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218327338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218327338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:58:09Z","timestamp":1762124289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369218327338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0012369218327338"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2018.11.006","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Combined \u03b2-Lactam\/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2018.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}